Gilman Hill Asset Management’s BioLife Solutions BLFS Stock Holding History

Gilman Hill Asset Management’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,000	Closed	-$223K	–	200
2021 Q2	$223K	Buy	+5,000	New	+$176K	0.06%	182
2021 Q1	–	Sell	-6,625	Closed	-$264K	–	182
2020 Q4	$264K	Sell	6,625 -3,375	-34%	-$115K	0.09%	147
2020 Q3	$289K	Hold	10,000	–	–	0.11%	134
2020 Q2	$164K	Sell	10,000 -2,500	-20%	-$34.5K	0.07%	154
2020 Q1	$119K	Buy	+12,500	New	+$172K	0.06%	152

Other funds holding BLFS

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Gilman Hill Asset Management's BLFS Position: Q3 2021 in Review

Gilman Hill Asset Management sold out of BioLife Solutions (BLFS) in Q3 2021, closing a stake of 5,000 shares — an estimated $223K sold.

Gilman Hill Asset Management first reported a position in BLFS in Q1 2020 and held it in 5 quarters. The position peaked at $289K in Q3 2020. 165 funds tracked by Wall St. Rank hold BLFS as of Q3 2021.

Gilman Hill Asset Management reported no remaining BioLife Solutions position as of Q3 2021 after selling out during the quarter.
Gilman Hill Asset Management sold 5,000 BioLife Solutions shares in Q3 2021, an estimated $223K.
Gilman Hill Asset Management first reported a position in BioLife Solutions in Q1 2020 and held it in 5 quarters.
Gilman Hill Asset Management's BioLife Solutions position peaked at $289K in Q3 2020.
165 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2021.

Based on Gilman Hill Asset Management's 13F filing for Q3 2021, filed 13 Oct 2021.